Table of Contents Author Guidelines Submit a Manuscript
Journal of Thyroid Research
Volume 2014, Article ID 165487, 6 pages
http://dx.doi.org/10.1155/2014/165487
Research Article

Association between TSH-Receptor Autoimmunity, Hyperthyroidism, Goitre, and Orbitopathy in 208 Patients Included in the Remission Induction and Sustenance in Graves’ Disease Study

1Department of Endocrinology, Aalborg University Hospital, 9000 Aalborg, Denmark
2Department of Clinical Medicine, Aalborg University, 9100 Aalborg, Denmark
3Department of Endocrinology and Internal Medicine, Herlev Hospital, 2730 Copenhagen, Denmark
4Department of Geriatric Medicine, Aalborg University Hospital, 9000 Aalborg, Denmark

Received 5 November 2013; Accepted 6 January 2014; Published 18 February 2014

Academic Editor: Jack R. Wall

Copyright © 2014 Peter Laurberg et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Lindholm and P. Laurberg, “Hyperthyroidism, exophthalmos, and goiter: historical notes on the orbitopathy,” Thyroid, vol. 20, no. 3, pp. 291–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Michalek, S. A. Morshed, R. Latif, and T. F. Davies, “TSH receptor autoantibodies,” Autoimmunity Reviews, vol. 9, no. 2, pp. 113–116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. I. B. Pedersen, A. Handberg, N. Knudsen, L. Heickendorff, and P. Laurberg, “Assays for thyroid-stimulating hormone receptor antibodies employing different ligands and ligand partners may have similar sensitivity and specificity but are not interchangeable,” Thyroid, vol. 20, no. 2, pp. 127–133, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. D. Lytton, Y. Li, P. D. Olivo, L. D. Kohn, and G. J. Kahaly, “Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulins,” Clinical and Experimental Immunology, vol. 162, no. 3, pp. 438–446, 2010. View at Google Scholar · View at Scopus
  5. P. Laurberg, G. Wallin, L. Tallstedt, M. Abraham-Nordling, G. Lundell, and O. Törring, “TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study,” European Journal of Endocrinology, vol. 158, no. 1, pp. 69–75, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Laurberg, “Remission of Graves' disease during anti-thyroid drug therapy. Time to reconsider the mechanism?” European Journal of Endocrinology, vol. 155, no. 6, pp. 783–786, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. J. L. Codaccioni, J. Orgiazzi, P. Blanc, M. Pugeat, R. Roulier, and P. Carayon, “Lasting remissions in patients treated for Graves' hyperthyroidism with propranolol alone: a pattern of spontaneous evolution of the disease,” Journal of Clinical Endocrinology and Metabolism, vol. 67, no. 4, pp. 656–662, 1988. View at Google Scholar · View at Scopus
  8. P. Abraham, A. Avenell, S. C. McGeoch, L. F. Clark, and J. S. Bevan, “Antithyroid drug regimen for treating Graves' hyperthyroidism,” Cochrane Database of Systematic Reviews, vol. 20, no. 1, Article ID CD003420, 2010. View at Google Scholar · View at Scopus
  9. R. S. Bahn, H. B. Burch, D. S. Cooper et al., “Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists,” Thyroid, vol. 21, no. 6, pp. 593–646, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. A. K. Eckstein, H. Lax, C. Lösch et al., “Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission,” Clinical Endocrinology, vol. 67, no. 4, pp. 607–612, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Elbers, M. Mourits, and W. Wiersinga, “Outcome of very long-term treatment with antithyroid drugs in Graves' hyperthyroidism associated with Graves' orbitopathy,” Thyroid, vol. 21, no. 3, pp. 279–283, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Laurberg, D. C. Berman, S. Andersen, and I. Bülow Pedersen, “Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe graves' orbitopathy,” Thyroid, vol. 21, no. 9, pp. 951–956, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Knudsen, B. Bols, I. Bülow et al., “Validation of ultrasonography of the thyroid gland for epidemiological purposes,” Thyroid, vol. 9, no. 11, pp. 1069–1074, 1999. View at Google Scholar · View at Scopus
  14. I. B. Pedersen, N. Knudsen, T. Jørgensen, H. Perrild, L. Ovesen, and P. Laurberg, “Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency,” Clinical Endocrinology, vol. 58, no. 1, pp. 36–42, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Gutekunst, W. Becker, R. Hehrmann, O. T. Olbricht Th., and P. Pfannenstiel, “Ultrasonic diagnosis of the thyroid gland,” Deutsche Medizinische Wochenschrift, vol. 113, no. 27, pp. 1109–1112, 1988. View at Google Scholar · View at Scopus
  16. C. H. Parry, Collections From the Unpublished Medical Writings of the Late Caleb Hilier Parry, vol. 2, Underwoods, London, UK, 1825.
  17. C. A. von Basedow, “Exophthalmos durch Hypertrophie des Zellgewebes in der Augenhöhle,” Wochenschr Gesamte Heilk, vol. 6, pp. 197–204, 1840. View at Google Scholar
  18. R. J. Graves, Clinical Lectures, Lecture XII, Barrington & Haswell, Philadelphia, Pa, USA, 1842.
  19. W. Meng, “Carl Adolph von Basedow—150th anniversary of his death,” Zeitschrift fur Arztliche Fortbildung und Qualitatssicherung, vol. 98, no. 5, pp. 7–12, 2004. View at Google Scholar · View at Scopus
  20. P. Laurberg, D. C. Berman, I. Bülow Pedersen, S. Andersen, and A. Carlé, “Incidence and clinical presentation of moderate to severe Graves' orbitopathy in a Danish population before and after iodine fortification of salt,” The Journal of Clinical Endocrinology & Metabolism, vol. 97, pp. 2325–2332, 2012. View at Publisher · View at Google Scholar
  21. P. Laurberg and I. B. Pedersen, “Measurements of TSH receptor antibodies in differential diagnosis,” Immuno-Analyse et Biologie Specialisee, vol. 21, no. 4, pp. 234–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Laurberg, P. E. Buchholtz Hansen, and E. Iversen, “Goitre size and outcome of medical treatment of Graves' disease,” Acta Endocrinologica, vol. 111, no. 1, pp. 39–43, 1986. View at Google Scholar · View at Scopus
  23. U. Schiemann, R. Gellner, B. Riemann et al., “Standardized grey scale ultrasonography in Graves' disease: correlation to autoimmune activity,” European Journal of Endocrinology, vol. 141, no. 4, pp. 332–336, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. J. W. vanIsselt, J. M. H. De Klerk, P. P. vanRijk et al., “Comparison of methods for thyroid volume estimation in patients with Graves' disease,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 30, no. 4, pp. 525–531, 2003. View at Google Scholar · View at Scopus
  25. T. Olsen, P. Laurberg, and J. Weeke, “Low serum triiodothyronine and high serum reverse triiodothyronine in old age. An effect of disease not age,” Journal of Clinical Endocrinology and Metabolism, vol. 47, no. 5, pp. 1111–1115, 1978. View at Google Scholar · View at Scopus
  26. P. R. Larsen, “Triiodothyronine: review of recent studies of its physiology and pathophysiology in man,” Metabolism, vol. 21, no. 11, pp. 1073–1092, 1972. View at Google Scholar · View at Scopus
  27. A. Carle, N. Knudsen, I. B. Pedersen et al., “Determinants of serum T4 and T3 at time of diagnosis in nosological types of thyrotoxicosis: a population-based study,” European Journal of Endocrinology, 2013. View at Publisher · View at Google Scholar
  28. P. Laurberg, H. Vestergaard, S. Nielsen et al., “Sources of circulating 3,5,3′-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 6, pp. 2149–2156, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Carlé, I. B. Pedersen, H. Perrild, L. Ovesen, T. Jørgensen, and P. Laurberg, “High age predicts low referral of hyperthyroid patients to specialized hospital departments: evidence for referral bias,” Thyroid, vol. 23, no. 12, pp. 1518–1524, 2013. View at Publisher · View at Google Scholar
  30. X. G. Vos, N. Smit, E. Endert, J. G. P. Tijssen, and W. M. Wiersinga, “Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study,” Clinical Endocrinology, vol. 69, no. 2, pp. 311–317, 2008. View at Publisher · View at Google Scholar · View at Scopus